Aimedis is already one of the most well-known eHealth platforms where patients can store and share their data, consult doctors, renew prescriptions and conduct therapy sessions without having to leave their homes. Based on this and the cooperation with clinics in several countries, doctors and therapists and a large number of patients who already use Aimedis, there is now one last chance to purchase the AIM with a high drawing bonus of up to 55% at BRIC INVEST – token buyers benefit from:
* 20% main sale bonus
* 5% BRIC new customer premium
* 5% for subscription of at least EUR 10,000
* another 25% for a holding period of at least 1 year! (As part of a special promotion, these tokens will be transferred along with the previous bonuses)
Those who subscribe to BRIC INVEST AIM tokens as part of this promotion will receive a general buyback offer of the tokens plus interest of 7% p.a. from Aimedis for token purchases of a minimum investment of EUR 500 or more, plus interest of 7% p.a. if the token should perform negatively. In the case of a token purchase of at least EUR 10,000, the buyer even has the option to choose between a stake in the company and a repurchase of the tokens, and this is confirmed by contract when the tokens are subscribed.
Important Note: This bonus campaign is limited to a maximum investment level of 500,000 EUR – get your AIMs now with the one-time BRIC-Bonus!
This digital asset offering offers token buyers the opportunity to participate in one of the most innovative and dynamic developments of our time: The Aimedis eHealth platform enables patients worldwide to access the best healthcare online, regardless of their current location. These include health services such as specialist consultations, obtaining second opinions, medical records by videoconference, and a wealth of other services related to health, therapy, and medication.
Thanks to integrated blockchain technology, 100% anonymity, transparency, and security are guaranteed in all health-related transactions – only the patient decides who is allowed to see which health data. In addition to the usual payment methods such as credit card and bank transfer, Aimedis already allows payment with the Aimedis Tokens (AIM) for the secure and anonymous payment of health services, which are increasingly accepted and refunded by health insurance companies.
So if you want to participate in the boom of tomorrow’s eHealth revolution today, you should take a closer look at Aimedis – currently, Aimedis is the only platform in the world that combines eHealth to this extent with blockchain technology, artificial intelligence, and cryptocurrencies in a profitable business model.
Why invest in Aimedis now?
(a) The Aimedis Token can be used since Q3 this year at Aimedis for the payment of medical services such as second opinion and medical advice.
Currently, the token is accepted by Aimedis for 0.15 USD for the payment of the above services, in the first half of 2020, the launch of its own exchange is planned to buy or sell the Aimedis token on demand. In the further course, a listing on established exchanges is still planned – this will be implemented after the clearly placement and establishment of the Aimedis token. Aimedis has deliberately refrained from early listing in order to protect the token buyers and to ensure the preservation of the value of the token. While Aimedis Services can be paid for at any time by other means such as credit card or cryptocurrencies such as Bitcoin, only the Aimedis Token offers an additional 10% discount on all services paid for with it. Currently, the token and its own wallet are integrated into the Aimedis V2 system, so that from Q2 2020 a complete payment of services within the system is possible.
b) Aimedis advanced clinical services launched
Aimedis launched several services in 2019, including some of Advanced Clinical Services such as the Aimedis QM and the Aimedis ICU module. Aimedis QM supports clinics and healthcare facilities such as practices in certification and quality management and simplifies the processing of data, documents and certification documents to ensure a smooth and fast process. Aimedis ICU supports emergency services and clinics in the often lengthy search for an intensive care bed for seriously ill patients.
c) Aimedis V2 started
Aimedis V2 was launched as planned in Q4 2019 and is currently being extensively tested in Europe and Asia, especially the topic of security plays a role in these tests, using both classic penetration tests and extensively planned hacker attacks to make the product one of the safest on the market. The Public Launch will take place in Q1 2020, please visit the Aimedis blog to be regularly informed about news.
d) Aimedis cooperates with Cankado from Cologne
Since this year, Aimedis has been cooperating with the Cankado health platform in the field of oncological patient care and supporting patients, doctors, and clinics in safe and guideline-oriented treatment.
e) Aimedis is active in consulting and human resources services
As you know, the Aimedis team has many years of experience in the field of healthcare and is expanding the Aimedis product portfolio with its consulting and human resources divisions. The platform also plays a decisive role and supports both the topic of eHealth in the field of consulting and the important topic of continuing education and training in the field of clinical lyre personnel.
f) Aimedis is now part of Digital Health Citizen Germany
Aimedis is proud to announce that it is now part of the Digital Health Citizen project Germany, which is launching in the Cologne and Bonn area. The project aims to ensure that up to 10 million German citizens initially store and securely manage their medical data and connect it to medical services such as online appointments, video chats with doctors, prescriptions and much more.
g) Certification for the connection to the Slovak eHealth
Currently, the certification for the connection to the Slovak eHealth System is carried out. Doctors in Slovakia will be required by law to use, among other things, Services supported by Aimedis and to offer them to their patients, so that a nationwide use of Aimedis will be possible.
Detailed information can be found on the Aimedis homepage.
Follow news and announcements on the Aimedis blog.
You can draw the AIM token via our page.
For more information visit our website.
R. Koromhaz +420 774 773 443
Rybna 24
CZ-11000 Prag 1
Disclaimer: This is a paid post and should not be considered as news/advice.
